XML 103 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 13 - Stock-Based Compensation
12 Months Ended
Jun. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 13. Stock Based Compensation


The Plan is administered by the Compensation Committee or such other Board committee (or the entire Board) as may be designated by the Board (the “Committee”). At June 29, 2014, the Company has reserved approximately 14.5 million shares of common stock for issuance, including options previously authorized for issuance under the 1999 Stock Incentive Plan.


The amounts of stock-based compensation expense recognized in the periods presented are as follows:


   

Years Ended

 
   

July 29,

2014

   

June 30,

2013

   

July 1,

2012

 
   

(in thousands, except per share data)

 

Stock options

  $ 420     $ 477     $ 1,073  

Restricted stock awards

    4,244       3,806       3,777  

Total

    4,664       4,283       4,850  

Deferred income tax benefit

    1,738       1,555       1,796  

Stock-based compensation expense, net

  $ 2,926     $ 2,728     $ 3,054  

Stock based compensation expense is recorded within the following line items of operating expenses:


   

Years Ended

 
   

July 29,

2014

   

June 30,

2013

   

July 1,

2012

 
   

(in thousands)

 

Marketing and sales

  $ 1,261     $ 1,499     $ 1,755  

Technology and development

    298       428       600  

General and administrative

    3,105       2,356       2,495  

Total

  $ 4,664     $ 4,283     $ 4,850  

Stock-based compensation expense has not been allocated between business segments, but is reflected as part of Corporate overhead. (Refer to Note 15. Business Segments).


Stock Option Plans 


The weighted average fair value of stock options on the date of grant, and the assumptions used to estimate the fair value of the stock options using the Black-Scholes option valuation model, were as follows:


   

Years ended

 
   

June 29,

2014

   

June 30,

2013

   

July 1,

2012

 

Weighted average fair value of options granted

  $ 3.16     $ 2.95     $ 1.84  

Expected volatility

    61%       72%       72%  

Expected life (in years)

    6.6       6.4       8.0  

Risk-free interest rate

    1.6%       0.7%       0.9%  

Expected dividend yield

    0.0%       0.0%       0.0%  

The expected volatility of the option is determined using historical volatilities based on historical stock prices. The Company estimated the expected life of options granted based upon the historical weighted average. The risk-free interest rate is determined using the yield available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the option. The Company has never paid a dividend, and as such the dividend yield is 0.0%.


The following table summarizes stock option activity during the year ended June 29, 2014:


   

Options

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (years)

   

Aggregate Intrinsic Value (000s)

 

Outstanding beginning of period

    4,723,240     $ 3.89                  

Granted

    25,000     $ 5.39                  

Exercised

    (164,050 )   $ 3.02                  

Forfeited/Expired

    (244,400 )   $ 6.34                  

Outstanding end of period

    4,339,790     $ 3.80       4.2     $ 10,188  

Options vested or expected to vest at end of period

    4,232,111     $ 3.83       4.2     $ 9,827  

Exercisable at June 29, 2014

    2,886,790     $ 4.52       2.8     $ 5,269  

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of fiscal 2014 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 29, 2014. This amount changes based on the fair market value of the Company’s stock. The total intrinsic value of options exercised for the years ended June 29, 2014, June 30, 2013 and July 1, 2012 was $0.4 million, $0.6 million, and $0.0 million, respectively.


The following table summarizes information about stock options outstanding at June 29, 2014:


       

Options Outstanding

   

Options Exercisable

 

Exercise Price

 

Options

Outstanding

   

Weighted-

Average

Remaining

Contractual Life (years)

   

Weighted-

Average

Exercise

Price

   

Options

Exercisable

   

Weighted-

Average

Exercise

Price

 
                                             

$1.69

– 1.79     1,013,500       6.3     $ 1.79       382,500     $ 1.79  

$2.01

– 2.63     1,054,900       7.3     $ 2.62       296,400     $ 2.62  

$2.87

– 3.11     1,041,303       2.0     $ 3.10       1,029,803     $ 3.10  

$3.26

– 6.52     650,234       2.4     $ 6.11       598,234     $ 6.08  

$6.90

– 9.95     579,853       1.0     $ 8.09       579,853     $ 8.09  
          4,339,790       4.2     $ 3.80       2,886,790     $ 4.52  

As of June 29, 2014, the total future compensation cost related to non-vested options not yet recognized in the statement of operations was $1.9 million and the weighted average period over which these awards are expected to be recognized was 4.8 years.


The Company grants shares of Common Stock to its employees that are subject to restrictions on transfer and risk of forfeiture until fulfillment of applicable service conditions and, in certain cases, holding periods (Restricted Stock).


The following table summarizes the activity of non-vested restricted stock during the year ended June 29, 2014:


   

Shares

   

Weighted

Average

Grant Date

Fair Value

 
                 

Non-vested – beginning of period

    3,433,355     $ 2.80  

Granted

    1,760,918     $ 5.09  

Vested

    (1,608,052 )   $ 2.50  

Forfeited

    (899,536 )   $ 4.52  

Non-vested - end of period

    2,686,685     $ 3.90  

The fair value of non-vested shares is determined based on the closing stock price on the grant date. As of June 29, 2014, there was $6.8 million of total unrecognized compensation cost related to non-vested restricted stock-based compensation to be recognized over a weighted-average period of 2.8 years.